Intas Pharmaceuticals Ltd

Intas is one of the fastest growing Indian pharmaceutical majors, having 2.51% share and 13.2% growth rate. Currently ranked at 12th, its focus on super-specialty in Central Nervous System (CNS), Nephrology, Gastroenterology, Urology, Orthopedics & Cardiology-diabetics segments has empowered its rapid ascendancy.

Intas operates through 33 exclusive and dedicated sales depots and has established relationships with over 4100 stockists in India. A dedicated sales representative team of 3000+ covers more than 1,50,000 doctors including specialists from different therapy areas. The company is set to enhance its presence in the market through its active progress in NDDS. Currently, Intas has launched 3 NDDS products in India using patented technology.

Intas's forte in delivering world-class products has earned it reputable presence in over 70 countries on the International pharmaceutical horizon, with 3000+ live product registrations. It has successfully augmented its R & D and manufacturing competency to enter into product alliances and strategic tie-ups and build business efficiencies for its partner companies. Intas customer base in Europe and US is multinational generic companies, retail pharma chains, distributors and hospitals. A territory specific marketing approach i.e. a mix of own marketing in select countries and tie ups with multinational companies in other markets, helps leverage its strong product basket and pipeline which also includes animal healthcare and bio-similar range of products.